OK Clinical Research | Edmond, OK
Status and phase
Conditions
Treatments
About
This study is designed to identify at least one dose of BHV-2100 that is safe and effective in reducing headache pain and other symptoms in the treatment of migraine.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Participants with at least 1 year history of migraine (with or without aura) consistent with a diagnosis according to the International Classification of Headache Disorders, 3rd Edition,19 including the following:
Key Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
575 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Chief Medical Officer
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal